How could nanobiotechnology improve treatment outcomes of anti-TNF-α therapy in inflammatory bowel disease? Current knowledge, future directions

How could nanobiotechnology improve treatment outcomes of anti-TNF-α therapy in inflammatory bowel disease? Current knowledge, future directions

Abstract Despite significant advances in therapeutic possibilities for the treatment of inflammatory bowel disease (IBD) in recent years, there is still a big room for improvement. In particular, biological treatment can induce not only clinical remission but also mucosal healing of the gastrointest...

Full description

Bibliographic Details
Main Authors: Piotr Eder, Aleksandra Zielińska, Jacek Karczewski, Agnieszka Dobrowolska, Ryszard Słomski, Eliana B. Souto
Format: Article
Language:English
Published: BMC 2021-10-01
Series:Journal of Nanobiotechnology
Subjects:
Anti-TNF-α antibodies therapy
Inflammatory bowel diseases
Lipid nanoparticles
Oral drug delivery
Online Access:https://doi.org/10.1186/s12951-021-01090-1

Internet

https://doi.org/10.1186/s12951-021-01090-1

Similar Items